The carotid plaque imaging in acute stroke (CAPIAS) study: protocol and initial baseline data
Authors:
- Anna Bayer-KarpinskaAnna Bayer-Karpinska
- Florian SchwarzFlorian Schwarz
- Frank A WollenweberFrank A Wollenweber
- Holger PoppertHolger Poppert
- Tobias Boeckh-BehrensTobias Boeckh-Behrens
- Alexander BeckerAlexander Becker
- Dirk A ClevertDirk A Clevert
- Konstantin NikolaouKonstantin Nikolaou
- Christian OpherkChristian Opherk
- Martin DichgansMartin Dichgans
- Tobias SaamTobias Saam
Open Access
- 13 December 2013
- journal article
- research article
- Published by Springer Nature in BMC Neurology
- Vol. 13 (1) , 201
Abstract
Background: In up to 30% of patients with ischemic stroke no definite etiology can be established. A significant proportion of cryptogenic stroke cases may be due to non-stenosing atherosclerotic plaques or low grade carotid artery stenosis not fulfilling common criteria for atherothrombotic stroke. The aim of the CAPIAS study is to determine the frequency, characteristics, clinical and radiological long-term consequences of ipsilateral complicated American Heart Association lesion type VI (AHA-LT VI) carotid artery plaques in patients with cryptogenic stroke. Methods/Design: 300 patients (age >49 years) with unilateral DWI-positive lesions in the anterior circulation and non- or moderately stenosing (<70% NASCET) internal carotid artery plaques will be enrolled in the prospective multicenter study CAPIAS. Carotid plaque characteristics will be determined by high-resolution black-blood carotid MRI at baseline and 12 month follow up. Primary outcome is the prevalence of complicated AHA-LT VI plaques in cryptogenic stroke patients ipsilateral to the ischemic stroke compared to the contralateral side and to patients with defined stroke etiology. Secondary outcomes include the association of AHA-LT VI plaques with the recurrence rates of ischemic events up to 36 months, rates of new ischemic lesions on cerebral MRI (including clinically silent lesions) after 12 months and the influence of specific AHA-LT VI plaque features on the progression of atherosclerotic disease burden, on specific infarct patterns, biomarkers and aortic arch plaques. Discussion: CAPIAS will provide important insights into the role of non-stenosing carotid artery plaques in cryptogenic stroke. The results might have implications for our understanding of stroke mechanism, offer new diagnostic options and provide the basis for the planning of targeted interventional studies. Trial Registration: NCT01284933Keywords
This publication has 41 references indexed in Scilit:
- Is the Montreal Cognitive Assessment Superior to the Mini-Mental State Examination to Detect Poststroke Cognitive Impairment?Stroke, 2011
- 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive SummaryJACC, 2011
- Association Between Carotid Plaque Characteristics and Subsequent Ischemic Cerebrovascular EventsStroke, 2006
- In Vivo Quantitative Measurement of Intact Fibrous Cap and Lipid-Rich Necrotic Core Size in Atherosclerotic Carotid PlaqueCirculation, 2005
- Quantitative Evaluation of Carotid Plaque Composition by In Vivo MRIArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Extracranial Thrombotically Active Carotid Plaque as a Risk Factor for Ischemic StrokeJAMA, 2004
- The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a reviewInternational Psychogeriatrics, 2004
- Coronary Plaque DisruptionCirculation, 1995
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Infarcts of undetermined cause: The NINCDS stroke data bankAnnals of Neurology, 1989